Haskap and Endurance Running Performance

NCT ID: NCT04837898

Last Updated: 2022-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-12

Study Completion Date

2021-12-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will employ a randomised, double-blind, placebo-controlled, independent groups experimental design. Submaximal, maximal and 5 km time trial running performance will be assessed before and after supplementation with haskap berry or a placebo.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will consume haskap berry powder or an isocaloric placebo for 7 days. They will be required to run on a treadmill before and after supplementation to asses the influence on the intervention on aerobic performance parameters. Other performance parameters such as blood lactate, heart rate, ratings of perceived exertion and respiratory variables will also be monitored throughout the various elements of the exercise trials.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exercise Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Supplement will be pre-weighed by an individual (independent of the study) and provided to participants in sealed packets

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Haskap berry

A commercially available haskap berry freeze-dried) powder

Group Type ACTIVE_COMPARATOR

Haskapa

Intervention Type DIETARY_SUPPLEMENT

Haskapa Ltd, Oxford, UK

Placebo

Black cherry KoolAid (Kraft Foods, USA) with added maltodextrin to match carbohydrate and calorie content

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

isocaloric to the haskap powder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Haskapa

Haskapa Ltd, Oxford, UK

Intervention Type DIETARY_SUPPLEMENT

Placebo

isocaloric to the haskap powder

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy non-smoking males
* completed a 5 km run (in less than 25 minutes) within the 6 weeks prior to the study

Exclusion Criteria

* female
* allergies to fruit or dairy, currently taking any nutritional supplements (e.g. vitamins, antioxidant, herbal or sports enhancing supplements) or medication that might affect the study outcome
* history of gastrointestinal, renal or cardiovascular disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mibelle Group Biochemistry

INDUSTRY

Sponsor Role collaborator

Haskapa Ltd

UNKNOWN

Sponsor Role collaborator

Northumbria University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northumbria University

Newcastle upon Tyne, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

26514

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Novel Iron-Based Supplement for Athletes Aged 14-17
NCT06338787 ACTIVE_NOT_RECRUITING NA
Mushroom Blend on Oxygen Kinetics
NCT02075892 COMPLETED NA